Posts Tagged: Paul Santerre

IBBME to Celebrate 50 Years by Looking 50 Years Ahead

A small instrument resembling a mini-chocolate grater may not look like much to the untrained eye, but an object like this is a glimpse into the future of medicine. On October 10, as part of its 50th Anniversary celebration, the…

A Golden Milestone for a Golden Anniversary

The Faculties of Applied Science & Engineering,  Dentistry  and  Medicine  recently gave the Institute of Biomaterials and Biomedical Engineering (IBBME) the perfect golden anniversary gift. IBBME Director Paul Santerre, along with Dean Cristina Amon of the Faculty of Applied Science & Engineering, Dean David…

Interface Biologics Inc. Announces $1-Million Investment by IAF-LS

U of T spin-off company, Interface Biologics Inc. (IBI), founded by Professor Paul Santerre (Director, IBBME), continues to garner technical and commercial success. On December 6, IBI announced a $1-million investment by Ontario’s Investment Accelerator Fund – Life Sciences (IAF-LS). The IAF-LS…

Future of Medicine is Smarter Implants

Biomedical implants have the potential to transform everything – from drug delivery, to orthopedics and neurology. They’re crucial to new treatments that will help meet the challenges posed by an aging population – and transform the practice of medicine. There’s…
Showing 25 - 30 of 36 results